GoodRx and Discount Cards vs Insurance: Which to Use

What a discount card is

Prescription discount cards, from companies such as GoodRx, are free to use. The company has set cash prices with pharmacies, and its card or app shows you the price at each one. You pay that price at the counter. It is not insurance: nothing is billed to a plan, and there is no premium, deductible or out-of-pocket limit.

Cash prices for the same drug can differ by tens of dollars between pharmacies in the same town, so compare more than one before you fill.

Card or insurance: one per fill

The pharmacy runs each prescription through either your insurance or the discount card. Because a card purchase is processed outside your insurance, the money you spend usually does not count toward your deductible or out-of-pocket maximum. Some plans let you send in the receipt to have it counted; ask yours before you rely on that.

A card can beat your insurance when:

• You have not met your deductible, so you would pay the plan’s full price anyway, and the card price is lower.
• Your plan does not cover the drug at all, and an exception request is not an option.
• The drug is a low-cost generic, where the cash price can be below your copay.

Insurance is the better choice when:

• You expect to reach your deductible or out-of-pocket maximum this year, since purchases outside the plan usually do not move you toward it.
• The drug is an expensive brand-name medicine, where even a discounted cash price is high.

The simplest habit: ask the pharmacist for both prices before you pay.

Why a card rarely fixes a brand-name drug bill

A discount card lowers a cash price, and for a brand-name drug that price starts near the list price. Of the 76 drugs mendmeds tracks with a typical monthly cost on record, 51 cost $1,000 a month or more before any help. The makers’ own programs are built for those drugs:

• Copay cards (121 of the 128 drugs we track) lower what you pay when you have private insurance. The claim still runs through your plan, though a copay accumulator can stop the card’s payments counting toward your deductible.
• Free-drug programs (109 drugs, all of them open to people without insurance) give the medicine free to people under an income limit. What patient assistance applications ask for covers the paperwork.
• Maker self-pay prices set a cash price without insurance, for Basaglar, Foundayo, Humalog, Lantus, Toujeo, Tresiba, Wegovy and Zepbound. Our GLP-1 cost comparison and insulin programs guide compare them.

A maker’s copay card is not the same thing as a discount card: a copay card usually works alongside your insurance, while a discount card replaces it for that fill. Our copay card vs patient assistance guide explains which maker program fits your coverage.

If you have Medicare

You can use a discount card instead of your Medicare drug plan for a fill, though not both together, and the makers’ copay cards are not allowed with Medicare at all.

If you pay with a discount card, your plan never sees the purchase, so it does not count toward your deductible or the yearly out-of-pocket cap ($2,100 in 2026). CMS puts the job on you: the purchase counts only if you send your plan the receipt, and only in narrow cases, such as a drug your plan covers bought at one of its network pharmacies while you are still paying the full price. Ask your plan how before you rely on it.

For a costly drug on Medicare, your plan usually does more than a card, together with Extra Help or a maker’s free-drug program if you qualify. Medicare’s negotiated prices for some of the most expensive drugs also reach you only through your plan.

Is GoodRx legit?

Yes, in the sense that the card is free and the prices are real. Two things are worth knowing. It is not insurance, so it gives you no protection from a large bill the way a plan’s out-of-pocket limit does. And discount apps collect information about your prescriptions: in February 2023 the Federal Trade Commission fined GoodRx $1.5 million for sharing users’ health information with companies including Facebook and Google, and the order permanently bars it from sharing health data for advertising. GoodRx disputed the allegations.